Do Wall Street Analysts Like Zimmer Biomet Stock?

Valued at a market cap of $20.4 billion, Zimmer Biomet Holdings, Inc. (ZBH) is a medical technology company based in Warsaw, Indiana. Its products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The company serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists. 

This medical technology company has underperformed the broader market over the past 52 weeks. Shares of ZBH have declined 6.5% over this time frame, while the broader S&P 500 Index ($SPX) has surged 16.4%. Moreover, on a YTD basis, the stock is down 2.7%, compared to SPX’s 9.7% uptick.